Concepedia

Yongxian Hu

YH

47

Publications

2.4K

Citations

23

H-Index

2013

Active since

Affiliations

Zhejiang University(Current)

First Affiliated Hospital Zhejiang University

Zhejiang Chinese Medical University

Zhejiang Lab

Tongji University

Yongxian Hu is an author at Zhejiang University specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2013–2025

47

Publications

47

Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL

Jiqin Zhang, Yongxian Hu, Jiaxuan Yang et al. · Nature · 2022 · 326 citations · Full text

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Clinical Cancer Research · 2021 · 263 citations · Full text

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Cell Research · 2022 · 178 citations · Full text

, , +8

GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial

Mingming Zhang, Guoqing Wei, Linghui Zhou et al. · The Lancet Haematology · 2023 · 156 citations

, , +5

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo et al. · Clinical Cancer Research · 2016 · 133 citations

Rows per page

1–5 of 47